Researchers at Geisinger Medical Center recently received funding totaling more than $44,000 from a Geisinger Health System (GHS) – NYU Langone Medical Center (NYULMC) collaborative project focusing on personalized healthcare.

MediSens Wireless, a startup company in UCLA’s on-campus technology incubator at the California NanoSystems Institute, has obtained approval under federal Food and Drug Administration guidelines to begin clinical trials on its novel wireless body-monitoring system, which assesses muscle and neuromotor functions in the upper extremities.

The American College of Physicians (ACP) today was one of 118 organizations that joined to send a letter to House and Senate leaders supporting equality of Medicaid and Medicare rates for primary care services. The co-signers include national and state organizations representing physicians, nurses, hospitals, and other health care providers; and consumer, labor, and other [...]

In a first-ever initiative, renowned health-care providers identify and describe how cancer treatment-related toxicities have a negative effect on quality of life from the perspective of patients and survivors. The findings of this study, made possible by CancerCare and Lindi Skin, are now available exclusively from the medical journal, Supportive Care in Cancer, here.

Quark Pharmaceuticals, Inc., the world leader in clinical development of RNAi-based therapeutics, announced that the independent Data Safety Monitoring Board (”DSMB”) recommended that QPI-1002 (I5NP) continue on to the next phase of clinical testing. This followed review of available safety data from two clinical trials for Quark’s siRNA QPI-1002, at doses up to 10 mg/kg, [...]